Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 33, 2018 - Issue 1
Research Paper
The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay
Jie XiaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of New Drug Research and Development, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Correspondence[email protected]
http://orcid.org/0000-0002-9567-3763View further author information
http://orcid.org/0000-0002-9567-3763View further author information, , , & Related Research Data
FRED Pose Prediction and Virtual Screening Accuracy
Source:
American Chemical Society (ACS)
Rescoring and Linearly Combining: a Highly Effective Consensus Strategy for Virtual Screening Campaigns
Source:
Molecular Diversity Preservation International (MDPI)
Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells.
Source:
Springer Science and Business Media LLC
Development of quantitative structure-binding affinity relationship models based on novel geometrical chemical descriptors of the protein-ligand interfaces
Source:
The University of North Carolina at Chapel Hill University Libraries
Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
Source:
Elsevier BV
HDAC3 Inhibitor RGFP966 Modulates Neuronal Memory for Vocal Communication Signals in a Songbird Model.
Source:
Frontiers Media SA
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma.
Source:
Springer Science and Business Media LLC
Structure-based virtual screening for drug discovery: principles, applications and recent advances.
Source:
Bentham Science Publishers Ltd.
The Development of Target-Specific Pose Filter Ensembles To Boost Ligand Enrichment for Structure-Based Virtual Screening
Source:
American Chemical Society (ACS)
Histone Deacetylase Inhibitors as Anticancer Drugs.
Source:
MDPI AG
Targeting the pancreatic β-cell to treat diabetes
Source:
Springer Science and Business Media LLC
Cheminformatics meets molecular mechanics: a combined application of knowledge-based pose scoring and physical force field-based hit scoring functions improves the accuracy of structure-based virtual screening.
Source:
American Chemical Society (ACS)
Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database
Source:
American Chemical Society (ACS)
Histone acetylation modifiers in the pathogenesis of malignant disease.
Source:
Springer Science and Business Media LLC
Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis
Source:
Elsevier Ltd.
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Source:
Elsevier BV
Histone deacetylase 3 inhibition improves glycaemia and insulin secretion in obese diabetic rats.
Source:
Wiley
HDAC3 Is a Critical Negative Regulator of Long-Term Memory Formation
Source:
Society for Neuroscience
An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection
Source:
American Chemical Society (ACS)
HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner
Source:
Proceedings of the National Academy of Sciences
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Source:
Springer Science and Business Media LLC
A library for support vector machines
Source:
Association for Computing Machinery (ACM)
Linking provided by
